Picture of virus

Open Access research that helps to deliver "better medicines"...

Strathprints makes available scholarly Open Access content by the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), a major research centre in Scotland and amongst the UK's top schools of pharmacy.

Research at SIPBS includes the "New medicines", "Better medicines" and "Better use of medicines" research groups. Together their research explores multidisciplinary approaches to improve understanding of fundamental bioscience and identify novel therapeutic targets with the aim of developing therapeutic interventions, investigation of the development and manufacture of drug substances and products, and harnessing Scotland's rich health informatics datasets to inform stratified medicine approaches and investigate the impact of public health interventions.

Explore Open Access research by SIPBS. Or explore all of Strathclyde's Open Access research...

Uptake of chromium into red blood cells does not affect the ability of haemoglobin to bind oxygen

Afolaranmi, G.A. and Tettey, J.N.A. and Gaylor, J.D.S. and Murray, H.M. and Meek, R.M.D. and Grant, M.H. (2008) Uptake of chromium into red blood cells does not affect the ability of haemoglobin to bind oxygen. Toxicology, 253 (1-3). pp. 15-16. ISSN 0300-483X

Full text not available in this repository. Request a copy from the Strathclyde author

Abstract

Many of the metallic implants used in orthopaedics are made of stainless steel or cobalt-chromium alloys which contain 18-30% chromium. Hexavalent chromium (Cr VI) has been shown to be the predominant form of chromium released following in vivo and in vitro corrosion of these metal implants (Merritt and Brown, 1995 K. Merritt and S.A. Brown, J. Biomed. Mater. Res. 29 (1995), pp. 627-633. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (67)Merritt and Brown, 1995). Blood chromium levels may be elevated between 50 and 250 times in patients with metal hip implants (Lhotka et al., 2003). At physiological pH, Cr (VI) exists predominantly as the chromate anion and as such can enter cells via non-specific anion channels. The anionic Cr (VI) diffuses readily through the red blood cell (RBC) membrane and is bound by the haemoglobin probably after its rapid reduction to the cationic trivalent state within the RBC (Gray and Sterling, 1950). The aims of this study were to investigate the effect of the presence of chromium in RBCs on oxygen uptake capacity of blood [oxyhaemoglobin saturation (O2-SAT) at specific pO2 values] and to evaluate the suitability of the two commonly used anti-coagulants, heparin and EDTA, for oxygen uptake studies.